A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase II Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablet in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women (Grace-2)

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 6865320dc06ce7665ef4f596bd702a12b5374529
First added on: Mar 22, 2025